Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has issued an announcement.
Asymchem Laboratories has issued a profit warning for 2024, forecasting a significant decrease in net profit by 54% to 63% compared to 2023, despite a 20% growth in new orders in the fourth quarter. This decline is attributed to the absence of large orders fulfilled in the previous year, reduced revenue from emerging businesses, and increased R&D expenses. However, the company maintained growth in its small molecule CDMO business and achieved strong order growth from European and American markets, indicating a solid foundation for future stability.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. operates in the pharmaceutical industry, focusing on contract development and manufacturing organization (CDMO) services, with a notable presence in small molecule and chemical macromolecule sectors. The company is expanding its market reach in emerging businesses and has a strong order growth from European and American markets.
YTD Price Performance: -4.86%
Average Trading Volume: 230,063
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$27.67B
Find detailed analytics on 6821 stock on TipRanks’ Stock Analysis page.
